NCT Number: NCT03024879
The Effect of Motilin on the Frequency and Amount of Food Intake
In this study, the investigators aimed at evaluating the role of motilin in the regulation of food intake. Motilin, a gastrointestinal hormone, is a hunger signal in healthy volunteers and is significantly increased in obese patients. Its role in food intake regulation might contribute to the pathogenesis of obesity.
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year–60 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- BMI < 30 kg/m² for lean volunteers
- BMI > 30 kg/m² for obese volunteers
- Subject is capable and willing to give informed consent
- Female volunteers of child bearing potential must use oral, injected or implanted hormonal methods of contraception
Exclusion criteria
- Female volunteer is pregnant or breastfeeding
- GI diseases, major abdominal surgery
- Major psychiatric illnesses
- Volunteers that use drugs affecting the GI tract or the central nervous system
- Volunteers suffering from endocrine diseases such as diabetes, Cushing's disease, Addison's disease, hypothalamic tumor
- Volunteers that have undergone surgical procedure for weight loss
Treatment and study plan
Saline
DrugPrimary outcomes
-
Change in food intake, assessed by caloric intake, after intravenous administration of erythromycin compared to placebo
Time frame: Caloric intake will be assessed 1 hour after the start of infusion and the start of ad libitum food intake
Secondary outcomes
-
Frequency of food intake correlated with motilin plasma levels
Time frame: Assessment will be done over a period of 5 hours
Sponsors and collaborators
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Other
Registry information
Official study title
Influence of Erythromycin on ad Libitum Food Intake and the Evaluation of Motilin in Food Timing in Healthy Volunteers and Patients
Important dates
- Study start
- 2014
- Primary completion
- 2025
- Study completion
- 2025
- First posted
- Jan 19, 2017
- Registry last updated
- Jul 10, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
NCT07407348
Body Weight, Healthy
Nottingham, United Kingdom
View Trial DetailsNew Heart Imaging Techniques to Evaluate Possible Heart Disease
NCT01399385
Arterial Occlusive Diseases, Arteriosclerosis
Bethesda, Maryland, United States
View Trial DetailsSex Disparities in Hypoxic Vasodilation and Impact of Obesity
NCT05219799
Aneurysm, Body Weight
Columbia, Missouri, United States
View Trial DetailsSex Disparities in Hypoxic Sympatholysis and Impact of Obesity
NCT04436731
Aneurysm, Body Weight
Columbia, Missouri, United States
View Trial Details